Medical Daily

Natera's Multi-Cancer Blood Test Gets FDA Breakthrough Status, a Faster Review Path That Is Not an Approval

The University of Kentucky alleges CVS Health diverted more than $41 million in 340B drug savings from four hospitals between 2020 and 2025. Judge Strikes Medicaid Test Forcing Chronically Ill ...
STAT

Why the FDA should not approve an ineffective multicancer screening test

Welch is a physician and cancer screening researcher at the Center for Surgery and Public Health at Brigham and Women’s Hospital in Boston. There must be some mistake. A company studies its cancer ...
KGW

'A groundbreaking finding': Multi-cancer blood test could be available to the public next year

PORTLAND, Oregon — A blood test designed to detect signals from more than 50 types of cancer could become available to the public as early as next year, according to researchers at Oregon Health & ...
U.S. News & World Report

FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works

FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works By Ellyn Vohnoutka HealthDay ReporterTHURSDAY, Sept. 24, 2026 (HealthDay News) — A blood test that aims to catch more than 50 ...
Becker's Hospital Review

FDA panel backs first multi-cancer blood test: What to know

The FDA’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee voted Sept. 23 in favor of approving Grail’s Galleri multi-cancer early-detection blood test. The vote marks ...
Healio

FDA panel: Benefits of Galleri blood test for multicancer detection outweigh risks

Please provide your email address to receive an email when new articles are posted on . The panel voted 7 to 2 with one abstention that the benefits of Galleri outweigh potential risks for multicancer ...
irblog.prnewswire.com

FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test

SUNNYVALE, Calif., Sept. 23, 2026 /PRNewswire/ -- GRAIL, Inc., a healthcare company whose mission is to detect cancer early when it can be cured, today announced a favorable vote from the Molecular ...
Wall Street Journal

Grail’s Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval

Grail Inc.GRAL4.83%increase; up pointing triangle received a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test.
STAT

FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks

Matthew Herper covers medical innovation — both its promise and its perils. A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail ...
StarTribune

Cancer blood test advances toward FDA approval after Mayo research

A blood test to detect multiple forms of cancer received support Wednesday from a federal health panel, one day after a Mayo Clinic-led study showed it discovered undiagnosed cases of lung, breast, ...
Queen Mary University of London

Major NHS trial provides new evidence on multi-cancer blood test

The NHS-Galleri trial, involving more than 140,000 people in England, evaluated whether adding the Galleri multi-cancer early detection (MCED) blood test to usual NHS care could reduce the number of ...
Semiconductor Engineering

Multi-die Testing In The Field Must Build On Established Test Methodologies

In-system testing is the very best way to ensure the longevity of data center and automotive hardware. A 2-die monitor, test, and repair strategy requires a modified test strategy and new ...